Endocrine Research Updates

For Medical Professionals

One pill delivering 3 forms of glucose lowering power improve outcome.
As the challenge of attaining better glucose control grows, introducing the first three-in-one therapy may lead to better outcomes with greater ease and lower cost.
Insulin clearance has been introduced as a factor in the onset of diabetes
A fresh look at factors affecting progression of type 2 diabetes led Cedars Sinai researchers to consider the possibility that insulin clearance in the liver may play a key role.
When adrenal mass is accidently seen on imaging, assessment may benefit patient.
The presence of adrenal incidentalomas appears increasingly more common and detecting these benign tumors reflects an increased rate of type 2 diabetes but any direct clinical meaning remains elusive, according to recent study findings.
Patients with Graves disease benefit from radioiodine treatment.
Despite conflicting findings, new data refuting any discernible link between increased risk of all cancers gains the endorsement of endocrine community.
Patients who choose radioactive iodine therapy to treat hyperthyroidism and Graves disease are not at increased risk for developing cancer, say experts.
Checking for adequate absorption of levothyroxine is critical in hypothyroidism.
The new clinical tool has been used effectively to identify cases of insufficient LT4 absorption
Treating Graves eye disease has been limited to surgery for the severest cases.
Teprotumumab (Tepezza) approved by FDA to make this first and only vision-preserving, pain-reducing treatment available to patients with Graves eye disease.
People who require insulin will welcome the advent of insulin biosimilars.
Recent regulatory actions clear path for development of insulin biosimilars, expands indications for Pure EPA, and fast paces first possible treatment for end-stage liver disease (NASH).
Diabetes patients who complain of joint pain should be heeded as a sign of gout.
Treating patients at risk for or diagnosed with type 2 diabetes should be closely monitored for gout-related disease.
Stem cell therapy is poised to bypass issues of transplant rejection.
Stem cell transplantation holds ever greater potential for improving glucose control in patients with type 1 diabetes; however, these same patients also face increased morbidity and mortality for cardiovascular disease, an ongoing hurdle.
Advances in stem cell transplantation may replace the need for insulin in type 1 diabetes and may lead to repair of damaged heart tissue following a heart attack.
A stepwise approach may improve detection of statin intolerance and better cholesterol-lowering management in patients who have had poor medication compliance despite their increased risk of both CVD and type 2 diabetes.
Patients with diabetes must be treated carefully to avoid common complications.
Expert panel addresses barriers to and advancements in achieving optimal hyperkalemia management aiming to improve outcomes regarding kidney disease and cardiovascular events in in patients with diabetes.
Study finds ticagrelor plus aspirin more effective in reducing ischemic cardiovascular events in patients with type 2 diabetes provided there is no heightened concern for excessive bleeding.
Hypertension is one of 5 key factors that indicate risk for metabolic syndrome.
Given the effectiveness of available interventions, the Endocrine Society issues a practice guideline to prompt proactive efforts at screening for the metabolic components leading to cardiovascular disease and type 2 Diabetes.
Malignancy of thyroid nodules can be informed by genetic variability.
Relying on molecular "rule-in" testing of thyroid nodules to better assess for cancer risk improves predictive value, based on a systematic review of the literature.
Older women at risk of bone loss should be treated cautiously with statins.
Benefit or detriment—New study raises potential adverse effects of statin therapy on bone health in patients with comorbid heart disease and osteoporosis. There are other complications necessitating specific considerations when prescribing statins in women at different ages and stages.
In seniors with diabetes, common disease complications respond well with SGLT2i
The latest study findings on the safety and efficacy of the SGLT-2i, ertugliflozin, offer strong assurance for use in managing diabetes in individuals at 65 years plus, and in others, without concerns for adverse effects on renal function.
Since up to 30% of patients with cancer experience insomnia, even years later, a team from Dana Farbar Cancer Institute has developed a stepwise approach to improve sleep and designed for ease of implementation in any practice setting.
Advances promise preservative-free, fast-acting inhaled insulin for diabetes.
Next Generation Soft-Mist Inhaled human Insulin and GLP-1RA are advancing for treatment of diabetes, and other hormone therapies are just beginning development.
Diabetes distress arises in patients overwhelmed with a chronic disease.
This often unrecognized response arises when individuals are overwhelmed when facing the responsibility of managing a chronic life-long disease. Thus, regular screening should become a routine aspect of diabetes patient care.
close X